KEGG   DRUG: Tinzaparin sodium
Entry
D06398                      Drug                                   
Name
Tinzaparin sodium (USAN);
Innohep (TN)
Class
Blood modifier agent
 DG01950  Antithrombotic agent
  DG01709  Heparin anticoagulant
Remark
ATC code: B01AB10
Chemical structure group: DG00150
Product (DG00150): D02112<JP/US> D04427<JP> D03674<JP/US> D04977<JP> D03353<JP/US>
Efficacy
Anticoagulant, Antithrombin III activator
Comment
Low molecular weight heparin (LMWH)
Target
SERPINC1 (AT3) [HSA:462] [KO:K03911]
  Pathway
hsa04610  Complement and coagulation cascades
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 B BLOOD AND BLOOD FORMING ORGANS
  B01 ANTITHROMBOTIC AGENTS
   B01A ANTITHROMBOTIC AGENTS
    B01AB Heparin group
     B01AB10 Tinzaparin
      D06398  Tinzaparin sodium (USAN)
Drug groups [BR:br08330]
 Blood modifier agent
  DG01950  Antithrombotic agent
   DG01709  Heparin anticoagulant
    DG00150  Heparin
     D06398  Tinzaparin sodium
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Organismal systems
   Complement and coagulation
    SERPINC1 (AT3)
     D06398  Tinzaparin sodium (USAN)
New drug approvals in the USA [br08319.html]
 New molecular entities and new therapeutic biological products
  D06398
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D06398
Drug groups [BR:br08330]
 Blood modifier agent
  DG01950  Antithrombotic agent
   DG01709  Heparin anticoagulant
    DG00150  Heparin
Other DBs
CAS: 9041-08-1
PubChem: 47208055
NIKKAJI: J209.198D
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system